ArticleVaccines2022

A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.

Sabine Schmidhuber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.